|
By Rhonda Siddall
15th February 2008
Genehan AG, Tyson M, Egger M, et al. BMI and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. The Lancet 371:569-578
INCREASED body mass index (BMI) increases the risk of common and less common cancers, new research has confirmed.
A paper published in this week’s Lancet also showed that the level of risk can vary between the sexes and different ethnic groups depending on the type of cancer.
Dr Andrew Renehan from the University of Manchester and Christie
Hospital NHS Foundation Trust and colleagues did a meta-analysis of 221
datasets incorporating 282,137 cases to determine the risk of cancer
associated with a 5 kg/m2 increase in BMI. They found, in men, a 5
kg/m2 increase in BMI raised the risk of oesophageal adenocarcinoma by
52%, thyroid cancer by 33%, and colon and kidney cancers each by 24%.
In women, a BMI increase of 5 kg/m2 increased the risk of endometrial
(59%), gallbladder (59%), oesophageal adenocarcinoma (51%) and kidney
(34%) cancers. They also noted weaker, but nonetheless significant,
positive associations between increased BMI and rectal cancer and
malignant melanoma in men; postmenopausal breast, pancreatic, thyroid,
and colon cancers in women; and leukaemia, multiple myeloma, and
non-Hodgkin’s lymphoma in both sexes. Associations were stronger in men
than in women for colon cancer (24% versus 9%). And while associations
were generally similar in studies from North America, Europe and
Australia, and the Asia-Pacific region, a stronger association between
increased BMI and both premenopausal and postmenopausal breast cancers
was recorded in Asia-Pacific populations. These findings extend those
reported by the World Cancer Research Fund last year, and those
published by the UK Million Women’s study team in November 2007.
The authors concluded: “Increased BMI is associated with increased risk
of common and less common malignancies. For some cancer types,
associations differ between sexes and populations of different ethnic
origins. These epidemiological observations should inform the
exploration of biological mechanisms that link obesity with cancer.”
In an accompanying editorial, Dr Susanna Larsson and Professor Alicja
Wolk from the Karolinska Institutet in Sweden, said: “The number of
deaths per year attributable to obesity is about 30, 000 in the UK and
ten times that in the USA, where obesity has been estimated to have
overtaken smoking in 2005 as the main preventable cause of illness and
premature death.”
They concluded: “Efforts will be needed to increase education on diet
and physical activity, train health professionals, restrict
advertisements of high-calorie and low-nutrient foods, limit access to
unhealthy foods in schools and workplaces, levy taxes on sugary drinks
and other foods high in calories, fat, or sugar, lower the prices of
health foods, and promote physical activity in schools and workplaces.
National cancer plans should include all these factors to reduce
obesity, and thus decrease cancer incidence and increase survival.”
Dr David Haslam, Clinical Director of the National Obesity Forum, said:
“The link between obesity and cancer has been observed for many years.
This new data further underlines that obesity is a serious medical
problem.”
National Obesity Chair Dr Colin Waine added: “ The government’s new
obesity strategy will address some of the issues raised by the
commentators from the Karolinska Institute that they, quite rightly,
suggest are means of tackling the obesity epidemic. This new research
throws the spotlight on the importance of continuing to recognise that
treatment and funding for obesity management programmes is vital so
that individuals affected receive appropriate professional treatment
and management based on their risk factors.”
|